Mayank Mamtani
Stock Analyst at B. Riley Securities
(4.07)
# 1,632
Out of 4,463 analysts
1093
Total ratings
39.2%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Mayank Mamtani
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNCY Unicycive Therapeutics | Maintained: Buy | $22 | $5.57 | +295.33% | 2 | Jun 30, 2026 | |
| KYMR Kymera Therapeutics | Rated: Buy | $117 → $155 | $112.40 | +37.90% | 4 | Jun 29, 2026 | |
| ELTX Elicio Therapeutics | Initiated Coverage: Buy | $27 | $3.44 | +684.88% | 1 | Jun 10, 2026 | |
| AAPG Ascentage Pharma Group International | Initiated Coverage: Buy | $45 | $18.08 | +148.89% | 1 | Jun 10, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $45 | $34.31 | +31.16% | 6 | May 29, 2026 | |
| MGNX MacroGenics | Maintained: Buy | $9 | $4.81 | +87.11% | 9 | May 22, 2026 | |
| NUVB Nuvation Bio | Maintained: Buy | $12 | $5.56 | +116.02% | 3 | May 21, 2026 | |
| HROW Harrow | Maintained: Buy | $65 → $60 | $42.86 | +39.99% | 29 | May 14, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $40 | $25.86 | +54.68% | 3 | Apr 10, 2026 | |
| NVAX Novavax | Maintained: Buy | $16 → $18 | $9.74 | +84.80% | 118 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $17 | $16.98 | +0.12% | 3 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.8794 | +241.14% | 16 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $7.15 | +67.83% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $4 | $1.35 | +197.40% | 17 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $12.75 | +103.92% | 1 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $7.70 | +185.71% | 25 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $25.85 | +16.05% | 25 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 | $87.20 | +23.85% | 23 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $150 | $66.31 | +126.21% | 9 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $9.45 | +196.30% | 3 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $33 | $21.49 | +53.56% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $55 | $52.69 | +4.38% | 65 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.49 | +1,242.28% | 1 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $11.60 | +270.69% | 5 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $16 | $18.09 | -11.55% | 22 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $3.20 | +462.50% | 71 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 | $37.79 | +124.93% | 34 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.48 | n/a | 82 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $83.25 | n/a | 78 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $422 → $460 | $527.33 | n/a | 57 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 → $2 | $0.56800002 | n/a | 35 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 → $2 | $1.16 | n/a | 23 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $36.95 | n/a | 1 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.10 | n/a | 30 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.6783 | n/a | 15 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.28 | n/a | 16 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $140 | $8.11 | n/a | 4 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $4.21 | n/a | 25 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.26 | n/a | 23 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0011 | n/a | 10 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.06 | n/a | 16 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.68 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.98 | n/a | 8 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.42 | n/a | 14 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.22 | n/a | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $120 | $12.58 | n/a | 7 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $10 | $13.66 | n/a | 14 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $28.33 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.85 | n/a | 26 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0005 | n/a | 7 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.20 | n/a | 19 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.67 | n/a | 7 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.57 | n/a | 11 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.36 | n/a | 10 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 18 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.48 | n/a | 4 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $30.62 | n/a | 1 | May 12, 2020 |
Unicycive Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $22
Current: $5.57
Upside: +295.33%
Kymera Therapeutics
Jun 29, 2026
Rated: Buy
Price Target: $117 → $155
Current: $112.40
Upside: +37.90%
Elicio Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $3.44
Upside: +684.88%
Ascentage Pharma Group International
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $18.08
Upside: +148.89%
ArriVent BioPharma
May 29, 2026
Maintained: Buy
Price Target: $45
Current: $34.31
Upside: +31.16%
MacroGenics
May 22, 2026
Maintained: Buy
Price Target: $9
Current: $4.81
Upside: +87.11%
Nuvation Bio
May 21, 2026
Maintained: Buy
Price Target: $12
Current: $5.56
Upside: +116.02%
Harrow
May 14, 2026
Maintained: Buy
Price Target: $65 → $60
Current: $42.86
Upside: +39.99%
Zymeworks
Apr 10, 2026
Reiterated: Buy
Price Target: $40
Current: $25.86
Upside: +54.68%
Novavax
Apr 9, 2026
Maintained: Buy
Price Target: $16 → $18
Current: $9.74
Upside: +84.80%
Apr 7, 2026
Maintained: Hold
Price Target: $14 → $17
Current: $16.98
Upside: +0.12%
Apr 7, 2026
Maintained: Buy
Price Target: $3
Current: $0.8794
Upside: +241.14%
Mar 26, 2026
Rated: Buy
Price Target: $12
Current: $7.15
Upside: +67.83%
Mar 25, 2026
Maintained: Buy
Price Target: $3 → $4
Current: $1.35
Upside: +197.40%
Mar 24, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $12.75
Upside: +103.92%
Mar 18, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $7.70
Upside: +185.71%
Mar 13, 2026
Reiterated: Buy
Price Target: $30
Current: $25.85
Upside: +16.05%
Mar 10, 2026
Reiterated: Buy
Price Target: $108
Current: $87.20
Upside: +23.85%
Feb 23, 2026
Maintained: Buy
Price Target: $105 → $150
Current: $66.31
Upside: +126.21%
Oct 6, 2025
Reiterated: Buy
Price Target: $28
Current: $9.45
Upside: +196.30%
Oct 3, 2025
Maintained: Buy
Price Target: $29 → $33
Current: $21.49
Upside: +53.56%
Sep 17, 2025
Maintained: Buy
Price Target: $53 → $55
Current: $52.69
Upside: +4.38%
Aug 26, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $1.49
Upside: +1,242.28%
Aug 19, 2025
Maintained: Buy
Price Target: $43
Current: $11.60
Upside: +270.69%
Aug 14, 2025
Maintained: Buy
Price Target: $20 → $16
Current: $18.09
Upside: -11.55%
Aug 13, 2025
Maintained: Buy
Price Target: $20 → $18
Current: $3.20
Upside: +462.50%
Jul 15, 2025
Maintained: Buy
Price Target: $85
Current: $37.79
Upside: +124.93%
Jul 1, 2025
Maintained: Buy
Price Target: $8
Current: $3.48
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $38
Current: $83.25
Upside: n/a
May 2, 2025
Maintained: Buy
Price Target: $422 → $460
Current: $527.33
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $2.5 → $2
Current: $0.56800002
Upside: n/a
Feb 6, 2025
Maintained: Buy
Price Target: $1.5 → $2
Current: $1.16
Upside: n/a
Jan 9, 2025
Initiated Coverage: Buy
Price Target: $21
Current: $36.95
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $3.10
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $0.6783
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $1.28
Upside: n/a
Jun 14, 2024
Reiterated: Buy
Price Target: $4 → $140
Current: $8.11
Upside: n/a
May 17, 2023
Reiterated: Buy
Price Target: $3 → $4
Current: $4.21
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $1.26
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.0011
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $2.06
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.68
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.98
Upside: n/a
Dec 15, 2022
Maintained: Buy
Price Target: $6
Current: $1.42
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $2.22
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $3 → $120
Current: $12.58
Upside: n/a
Mar 23, 2022
Maintained: Buy
Price Target: $17 → $10
Current: $13.66
Upside: n/a
Nov 12, 2021
Maintained: Buy
Price Target: $67
Current: $28.33
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $4.85
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $10.20
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $4.67
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $0.57
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $2.36
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $10.48
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $30.62
Upside: n/a